Skip to main content

Biobanks – Banks for Efficient Drug Discovery

If you or your loved ones are diagnosed with a disease or illness tomorrow, you have to go to the pharmacy and pick up the right prescription.  However, an effectual treatment for the disease you are looking for may not be available yet. Discovering and developing the right treatment options requires volunteers to step ahead and offer their health information to researchers. Data can accelerate research and services, help get better patient outcomes and save money. Imagine how helpful it would be if all of us offered our health information so that there was no lack of health data.

As a result of increasing orientation towards the medical research on the molecular and genetic level, a new kind of bank containing data and samples has come into being. Biobanks are the libraries of human organism where you can find huge deposits of biological samples taken from patients with different conditions. The wide array of bio specimens stored in biobanks includes blood, saliva, plasma, and purified DNA. Biobanks catalog specimens using genetic and other traits, such as gender, age, blood type, and ethnicity. Researchers access these biobanks when they are in need of specimen with similar traits for their research study. For example, a researcher can find a specific blood sample associated with a European male aged 50 who has a habit of smoking for the past 10 years.


In recent years, commercial organizations and governments have begun funding large-scale “biobanks.” Population biobanks are the most common type of biobanks started in many countries such as United Kingdom, Iceland, Italy, Israel and Sweden. Origins of biobanks in United States are shown below based on their year of establishment. It has been estimated that over 270 million tissue samples were stored in the United States repository, expanding at a rate of 20 million samples annually.


Serum or plasma, Solid tissue specimens, including paraffin-embedded, frozen, Whole blood, Peripheral blood cells or bone marrow, Cell lines, Saliva or buccal cells, Urine or stool, Cerebral spinal fluid, Cord blood or cord blood derivatives, other biological specimens, Pathological body fluids and Hair/toenails are the most commonly stored specimens stored in biobank. Biobanks hold the key to the future of breakthroughs in scientific research and drug discovery.

Current medical product development path is becoming increasingly challenging, inefficient and costly leading to increasing concerns in the new science discoveries because of increasingly challenging medical product development path. During the past decade a number of new drugs and biologic applications submitted to FDA have declined significantly. To withstand the growing complexities in medical product development and make it cost effective biobanking has been identified as a key sector to accelerate growth. According to a recent report, global biobanks have been increasing rapidly since the 1970s with a growth of 42% in 1990–1999 and a further increase in the last decade of 36%, and looks likely to continue to expand in the coming years as researchers continue to favour human tissues and biomaterials for pharmaceutical and diagnostic research.


A recent study showed that the amount of time a blood sample is stored in a biobank may affect the as much as any other essential parameter. Until now, medical research has taken into account age, sex and health factors of the person providing the sample but after the analysis of over 380 different samples, it is confirmed that storage has a significant impact on the test results.

According to a recent update blood samples of lipemia caused by chylomicrons can be cleared using the Lipemic Serum Clarification System from Beckman Coulter. Chylomicrons are fat particles, with a diameter of 80–500nm in diameter, that affects the accuracy of the results. Scientific Lab Supplies (SLS) has announced a distribution deal with UK based LabMode for the complete range of Taylor Wharton cryogenic storage systems.  The synergy between SLS and LabMode is likely to ensure the offering everything a person needs within a cryopreservation environment.

To find out more on the Biobank in the healthcare domain, checkout Market Data Forecast’s comprehensive research report “Global Biobanks” equipped with exhaustive segmentation, wide ranging geographical analyses complete with list of the drivers and restraints, company profiles, and strategic analysis. Contact now for your free report sample and subscribe to our newsletters to make your decisions researched and well-versed.

Leave a Reply

Your email address will not be published. Required fields are marked *